Anagenex is building a novel platform for drug discovery focusing on difficult targets.

Anagenex's technology analyzes 100-1000x more compounds compared to traditional approaches by combining machine learning with DNA Encoded Libraries.

• Industry

  • AI & Machine Learning
  • Biotechnology
  • Health + Tech

• Milestones

  • Lux investment: 2019

• Founders

  • Nicolas Tilmans, PhD
  • Zavain Dar

  LUX Partners

  • Zavain Dar

• Latest Tweets

  • Welcome @henripal to the team! Henri is a fantastic ML Engineer with a deep understanding of biochemistry and machi… https://t.co/SXGYmaLprm@anagenex - 05:32 PM Dec 11th
  • Welcome to our new Biochemist, Meghan Lawler! She is a creative, driven biochemist whose experience ranges from pep… https://t.co/ZZ7eieZtXn@anagenex - 06:34 PM Dec 1st
  • And we have started on chemistry, @joefranklin77 with our first ethanol precipitation! https://t.co/8SYe4lK7JY@anagenex - 04:57 PM Nov 19th